265 related articles for article (PubMed ID: 29514158)
1. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
John A; Baumgart A; Worst T; Heinzelbecker J
Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
[TBL] [Abstract][Full Text] [Related]
2. Testicular cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli J; Michaeli D
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2249-2258. PubMed ID: 33885951
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.
Kamran SC; Seisen T; Markt SC; Preston MA; Trinh QD; Frazier LA; Choueiri TK; Martin NE; Nguyen PL; Beard CJ
Eur Urol; 2018 Feb; 73(2):262-270. PubMed ID: 28687143
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive systematic review of testicular germ cell tumor surveillance.
Groll RJ; Warde P; Jewett MA
Crit Rev Oncol Hematol; 2007 Dec; 64(3):182-97. PubMed ID: 17644403
[TBL] [Abstract][Full Text] [Related]
5. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
[TBL] [Abstract][Full Text] [Related]
6. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
7. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.
Kopp RP; Chevinsky M; Bernstein M; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2017 May; 103():154-160. PubMed ID: 27816603
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
10. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract][Full Text] [Related]
11. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
Actas Urol Esp; 2012 Mar; 36(3):127-45. PubMed ID: 22188753
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of clinical stage I testicular cancer patients: cost and risk benefit considerations.
Kakehi Y; Kamoto T; Kawakita M; Ogawa O
Int J Urol; 2002 Mar; 9(3):154-60; discussion 160-1. PubMed ID: 12010325
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of testicular germ cell tumors relapse].
Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
[TBL] [Abstract][Full Text] [Related]
15. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
Heidenreich A; Pfister D
Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
[TBL] [Abstract][Full Text] [Related]
17. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
Krege S; Beyer J; Souchon R; Albers P; Albrecht W; Algaba F; Bamberg M; Bodrogi I; Bokemeyer C; Cavallin-Ståhl E; Classen J; Clemm C; Cohn-Cedermark G; Culine S; Daugaard G; De Mulder PH; De Santis M; de Wit M; de Wit R; Derigs HG; Dieckmann KP; Dieing A; Droz JP; Fenner M; Fizazi K; Flechon A; Fosså SD; del Muro XG; Gauler T; Geczi L; Gerl A; Germa-Lluch JR; Gillessen S; Hartmann JT; Hartmann M; Heidenreich A; Hoeltl W; Horwich A; Huddart R; Jewett M; Joffe J; Jones WG; Kisbenedek L; Klepp O; Kliesch S; Koehrmann KU; Kollmannsberger C; Kuczyk M; Laguna P; Galvis OL; Loy V; Mason MD; Mead GM; Mueller R; Nichols C; Nicolai N; Oliver T; Ondrus D; Oosterhof GO; Ares LP; Pizzocaro G; Pont J; Pottek T; Powles T; Rick O; Rosti G; Salvioni R; Scheiderbauer J; Schmelz HU; Schmidberger H; Schmoll HJ; Schrader M; Sedlmayer F; Skakkebaek NE; Sohaib A; Tjulandin S; Warde P; Weinknecht S; Weissbach L; Wittekind C; Winter E; Wood L; von der Maase H
Eur Urol; 2008 Mar; 53(3):478-96. PubMed ID: 18191324
[TBL] [Abstract][Full Text] [Related]
18. Testicular cancer guideline adherence and patterns of care in Germany: A nationwide survey.
Nestler T; Baunacke M; Dräger D; von Landenberg N; Groeben C; Huber J
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12917. PubMed ID: 30252174
[TBL] [Abstract][Full Text] [Related]
19. EAU guidelines on testicular cancer: 2011 update.
Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
Eur Urol; 2011 Aug; 60(2):304-19. PubMed ID: 21632173
[TBL] [Abstract][Full Text] [Related]
20. What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: an analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients.
Clasen J; Schmidberger H; Souchon R; Weissbach L; Hartmann M; Hartmann JT; Hehr T; Bamberg M
Strahlenther Onkol; 2009 Jun; 185(6):349-54. PubMed ID: 19506817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
